Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Retained Earnings (2016 - 2025)

Wave Life Sciences' Retained Earnings history spans 11 years, with the latest figure at -$250000.0 for Q4 2025.

  • For Q4 2025, Retained Earnings rose 4.58% year-over-year to -$250000.0; the TTM value through Dec 2025 reached -$250000.0, up 4.58%, while the annual FY2025 figure was -$250000.0, 4.58% up from the prior year.
  • Retained Earnings reached -$250000.0 in Q4 2025 per WVE's latest filing, down from -$190000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $269000.0 in Q2 2021 to a low of -$1.2 billion in Q1 2025.
  • Average Retained Earnings over 5 years is -$377.7 million, with a median of -$224000.0 recorded in 2024.
  • Peak YoY movement for Retained Earnings: soared 100.04% in 2021, then tumbled 2161274.47% in 2023.
  • A 5-year view of Retained Earnings shows it stood at -$805.5 million in 2021, then decreased by 20.09% to -$967.3 million in 2022, then soared by 99.99% to -$124000.0 in 2023, then crashed by 111.29% to -$262000.0 in 2024, then increased by 4.58% to -$250000.0 in 2025.
  • Per Business Quant, the three most recent readings for WVE's Retained Earnings are -$250000.0 (Q4 2025), -$190000.0 (Q3 2025), and -$161000.0 (Q2 2025).